Lawsuit Overview
July 1, 2016 (Shareholders Foundation) - An investor who currently holds shares of Celator Pharmaceuticals Inc (NASDAQ:CPXX), filed a lawsuit in effort to halt the proposed takeover of Celator Pharmaceuticals. by Jazz Pharmaceuticals plc for $30.25 per share. The plaintiff alleges that the defendants breached their fiduciary duties owed to NASDAQ:CPXX stockholders by agreeing to sell...
You must register (for free) or login to view the entire case.